Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MREO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
57 filers reported a long position in MREO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Rubric Capital Management LP | $4.9M | 15.3M | Unchanged |
| 683 Capital Management, LLC | $3.7M | 11.8M | -1.9% |
| BANK OF AMERICA CORP /DE/ | $2.6M | 8.2M | 0% |
| Defilade Capital Management, L.P. | $2.4M | 7.6M | Unchanged |
| Newtyn Management, LLC | $953.1K | 3M | -57.6% |
| Tejara Capital Ltd | $647.3K | 2M | Unchanged |
| UBS Group AG | $460.3K | 1.4M | -2.9% |
| TWO SIGMA INVESTMENTS, LP | $419.1K | 1.3M | +602.3% |
| EcoR1 Capital, LLC | $317.7K | 1M | -92.5% |
| JANE STREET GROUP, LLC | $246.2K | 774.9K | +453.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.